Nanosonics Limited (NNCSF)
OTCMKTS · Delayed Price · Currency is USD
2.650
0.00 (0.00%)
At close: Feb 9, 2026
Nanosonics Revenue
In the fiscal year ending June 30, 2025, Nanosonics had annual revenue of 198.63M AUD with 16.83% growth. Nanosonics had revenue of 105.03M in the half year ending June 30, 2025, with 24.41% growth.
Revenue
198.63M AUD
Revenue Growth
+16.83%
P/S Ratio
6.13
Revenue / Employee
422.61K AUD
Employees
470
Market Cap
798.90M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 198.63M | 28.62M | 16.83% |
| Jun 30, 2024 | 170.01M | 4.02M | 2.42% |
| Jun 30, 2023 | 165.99M | 45.67M | 37.96% |
| Jun 30, 2022 | 120.32M | 17.24M | 16.73% |
| Jun 30, 2021 | 103.08M | 3.03M | 3.02% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Meihua International Medical Technologies | 89.55M |
| InnerScope Hearing Technologies | 14.51M |
| Encision | 6.30M |
| Lancer Orthodontics | 6.19M |
| Reflect Scientific | 1.72M |
| Ozop Energy Solutions | 323.50K |
| Standard Dental Labs | 306.82K |
| Cardiac Biotech Solutions | 50.37K |
Nanosonics News
- 3 months ago - Nanosonics Limited (NNCSF) Shareholder/Analyst Call Transcript - Seeking Alpha
- 6 months ago - Nanosonics Limited 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 6 months ago - Nanosonics Limited (NNCSF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 10 months ago - Billion-dollar medical start-ups say Trump could force a US move - The Australian Financial Review
- 1 year ago - Nanosonics Limited 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 1 year ago - Nanosonics targets 11%-14% revenue growth for FY 2025 driven by North American expansion - Seeking Alpha
- 1 year ago - Nanosonics Limited (NNCSF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Nanosonics Ltd (NNCSF) (H1 2025) Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus